Open AccessThymic malignancies: next-generation sequencing as a tool to select patients for targeted therapies and immunotherapies?
Author(s) -
Nicolas Girard
Publication year - 2019
Publication title -
mediastinum
Language(s) - English
Resource type - Journals
ISSN - 2522-6711
DOI - 10.21037/med.2019.09.03
Subject(s) - medicine , immunotherapy , immune system , pi3k/akt/mtor pathway , oncology , bioinformatics , cancer research , immunology , biology , signal transduction , biochemistry